zidovudine has been researched along with proline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| North, TW; Preston, BD; Remington, KM; Schinazi, RF; Smith, RA | 1 |
| Klarmann, GJ; North, TW; Preston, BD; Schinazi, RF; Smith, RA | 1 |
2 other study(ies) available for zidovudine and proline
| Article | Year |
|---|---|
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cats; Cell Line; Drug Interactions; Drug Resistance, Microbial; Immunodeficiency Virus, Feline; Lamivudine; Molecular Sequence Data; Mutagenesis, Site-Directed; Point Mutation; Proline; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Serine; Viral Plaque Assay; Zidovudine | 1998 |
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site.
Topics: Catalytic Domain; Cytidine Triphosphate; Dideoxynucleotides; Dose-Response Relationship, Drug; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Lamivudine; Mutation; Proline; Reverse Transcriptase Inhibitors; Thionucleosides; Thiophenes; Thymine Nucleotides; Transcription, Genetic; Zalcitabine; Zidovudine | 2000 |